Please try another search
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.
Name | Age | Since | Title |
---|---|---|---|
Douglas Jay Cohen | 52 | 2020 | Lead Independent Director |
Alison Tjosvold Milhous | 44 | 2020 | Independent Director |
David Gobel | 70 | 2020 | Independent Director |
Keith E. Murphy | 52 | 2007 | Executive Chairman |
Vaidehi Joshi | 37 | 2022 | Director of Discovery Biology & Director |
Adam K. Stern | 60 | 2020 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review